drugset / Trial / NCT00813267
Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head
NaSingle-groupOpen-labelTreatment
Summary
Mesenchymal Stem Cells (MSCs) have been shown to have immunosuppressive and repairing properties. Bone marrow mononuclear cells (BMMNCs) have revascularization properties and complimentary effects to MSCs. The investigators will infuse expanded autologous MSCs and BMMNCs into patients with osteonecrosis of the femoral head. The study purpose is to examine whether this treatment will result in improvement in osteonecrosis of the femoral head.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | — | Other |
| Subject | bone marrow mononuclear cell | Cell therapy | — | Other |